SCHEMBL10119356

SCHEMBL10119356

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3)cc2)cc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.47
CA9 Q16790 2/20 0.47
CA2 P00918 1/20 0.47
PTPN1 P18031 2/20 0.46
SCN3A Q9NY46 2/20 0.46
SCN9A Q15858 1/20 0.46
HDAC1 Q13547 2/20 0.45
HDAC3 O15379 1/20 0.45
HDAC4 P56524 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45
HDAC5 Q9UQL6 1/20 0.45
KCNK3 O14649 1/20 0.45
KCNK9 Q9NPC2 1/20 0.45
MMP2 P08253 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16741983 0.90 SCN3A (0.52) SCN3ASCN9AHDAC1HDAC3HDAC4
Hydrochloric Acid SCHEMBL16741981 0.90 SCN3A (0.52) SCN3ASCN9AHDAC1HDAC3HDAC4
SCHEMBL845510 0.89 SCN3A (0.54) SCN3ASCN9AHDAC1HDAC3HDAC4
SCHEMBL2707503 0.86 SCN3A (0.54) SCN3ASCN9APSMB8
SCHEMBL10119360 0.82 HDAC3 (0.43) SCN3ASCN9AHDAC1HDAC3HDAC4
SCHEMBL2172641 0.82 HPGD (0.56) SCN3ASCN9AHDAC1HDAC3HDAC4
SCHEMBL9352214 0.82 HPGD (0.56) SCN3ASCN9AHDAC1HDAC3HDAC4
SCHEMBL2392383 0.82 HPGD (0.56) SCN3ASCN9AHDAC1HDAC3HDAC4
Hydrochloric Acid SCHEMBL4306381 0.80 SCN3A (0.56) SCN3ASCN9AHDAC1HDAC3HDAC4
SCHEMBL17676966 0.79 SCN3A (0.59) PTPN1SCN3ASCN9AHDAC1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed